Work

Sat0370 Tumour Necrosis Factor Inhibitor Therapy Does Not Reduce the Incidence of Comorbidities and Extra-articular Manifestations in Ankylosing Spondylitis: an Analysis of Three Us Claims Databases

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.4201

Authors: A. Deodhar, K. Winthrop, R. Bohn, B. Chan, R. Suruki, J. Stark, H. Yun, S. Siegel, L. Chen, J. Curtis

Institutions: Oregon Health & Science University, UCB Pharma (United States), University of Alabama at Birmingham

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Gilead Sciences, Genentech, UCB Pharma

OpenAlex ID: W3042371681

Cites: 1

Cited by: 8

Related to: 10